Presentations

Presentations

The GENFI investigators have presented their work as either invited talks or posters at a number of different international meetings and conferences.

Invited talks

11th ICFTD (Sydney, November 2018)

  • Mario Masellis (Toronto): Cerebral Blood Flow In Regions Showing Pre-Symptomatic Hypoperfusion Is Associated With Memory And Orientation Impairments – A GENFI Study

Posters

11th ICFTD (Sydney, November 2018)

  • Rhian Convery (UCL): Presymptomatic abnormal perception of pain in C9orf72 expansions carriers: early autonomic changes in the GENFI cohort
  • Dorothy Gors (Leuven): Presymptomatic abnormalities in segmental size and shape of the brain in monogenic FTLD
  • Caroline Greaves (UCL): Comparing clinical rating scales in genetic frontotemporal dementia within the GENFI cohort
  • Carolin Heller (UCL): Plasma GFAP levels are increased in symptomatic FTD mutation carriers within the GENFI cohort
  • Katrina Moore (UCL): GENFI-Cog: Developing a cognitive composite score for presymptomatic genetic FTD therapeutic trials (Datablitz talk)
  • Mollie Neason (UCL): Presymptomatic impairment of social behaviour in MAPT mutation carriers within the GENFI cohort (Datablitz talk)
  • Linn Öijerstedt (Stockholm): Does IQ influence cognitive performance in presymptomatic mutation carriers in genetic FTD?
  • Tim Rittman (Cambridge): In genetic FTD, functional network efficiency is maintained until the onset of symptoms: evidence for functional resilience to structural change
  • Lucy Russell (UCL): Social cognitive impairment in familial frontotemporal dementia: results from the GENFI study
  • Roser Sala-Llonch (Barcelona): Distinct age-related cortical thinning in asymptomatic progranulin (GRN) mutation carriers
  • Tamara Tavares (London Ontario): Ventricular Volume Expansion in Pre-symptomatic Genetic Frontotemporal Dementia
  • Emma van der Ende (Rotterdam): Longitudinal neurofilament light chain in blood in genetic frontotemporal dementia
  • Ione Woollacott (UCL): CSF microglia-derived biomarkers in familial frontotemporal dementia: results from the GENFI study